These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20950331)

  • 41. How to manage aspergillosis in non-neutropenic intensive care unit patients.
    Bassetti M; Righi E; De Pascale G; De Gaudio R; Giarratano A; Mazzei T; Morace G; Petrosillo N; Stefani S; Antonelli M
    Crit Care; 2014 Jul; 18(4):458. PubMed ID: 25167934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspergillus tracheobronchitis in critically ill patients with chronic obstructive pulmonary diseases.
    He H; Jiang S; Zhang L; Sun B; Li F; Zhan Q; Wang C
    Mycoses; 2014 Aug; 57(8):473-82. PubMed ID: 24673772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolonged survival after invasive aspergillosis: a single-institution review of 11 cases.
    Wright JA; Bradfield SM; Park JR; Hawkins DS
    J Pediatr Hematol Oncol; 2003 Apr; 25(4):286-91. PubMed ID: 12679641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Baseline predictors influencing the prognosis of invasive aspergillosis in adults.
    Koehler P; Salmanton-García J; Gräfe SK; Koehler FC; Mellinghoff SC; Seidel D; Steinbach A; Cornely OA
    Mycoses; 2019 Aug; 62(8):651-658. PubMed ID: 31066092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease].
    Barberán J; Mensa J
    Rev Iberoam Micol; 2014; 31(4):237-41. PubMed ID: 25481431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa.
    Yerbanga IW; Nakanabo Diallo S; Rouamba T; Denis O; Rodriguez-Villalobos H; Montesinos I; Bamba S
    J Mycol Med; 2023 Mar; 33(1):101328. PubMed ID: 36265260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review.
    Bernardeschi C; Foulet F; Ingen-Housz-Oro S; Ortonne N; Sitbon K; Quereux G; Lortholary O; Chosidow O; Bretagne S;
    Medicine (Baltimore); 2015 Jul; 94(26):e1018. PubMed ID: 26131805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Epidemiology of and risk factors for invasive aspergillosis in nonneutropenic patients].
    Gangneux JP; Camus C; Philippe B
    Rev Mal Respir; 2008 Feb; 25(2):139-53. PubMed ID: 18449076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive Aspergillosis in a Patient With Diabetes Mellitus as the Only Risk Factor: Case Report and Literature Review.
    Fernández-Trujillo L; Eraso I; Morales EI; Sua LF
    J Investig Med High Impact Case Rep; 2023; 11():23247096231175443. PubMed ID: 37203376
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Invasive pulmonary aspergillosis in non-neutropenic patients].
    Tejeda MI; Salso S; Barberán J
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():56-8. PubMed ID: 27608316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016.
    Alarcón-Manoja E; Cardozo-Espinola C; Puerta-Alcalde P; García-Vidal C
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():26-29. PubMed ID: 28882011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspergillosis: Emerging risk groups in critically ill patients.
    Kluge S; Strauß R; Kochanek M; Weigand MA; Rohde H; Lahmer T
    Med Mycol; 2021 Dec; 60(1):. PubMed ID: 34677613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta-analysis.
    Shi C; Shan Q; Xia J; Wang L; Wang L; Qiu L; Xie Y; Lin N; Wang L
    Mycoses; 2022 Feb; 65(2):152-163. PubMed ID: 34882852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the epidemiology, prevention and treatment of invasive fungal infections in neutropenic patients.
    Walsh TJ; De Pauw B; Anaissie E; Martino P
    J Med Vet Mycol; 1994; 32 Suppl 1():33-51. PubMed ID: 7722797
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical trial design for invasive aspergillosis: time to cast a different mold.
    Miceli M; Anaissie E
    Med Mycol; 2009; 47 Suppl 1():S343-8. PubMed ID: 19253146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why are so many cases of invasive aspergillosis missed?
    Danion F; Rouzaud C; Duréault A; Poirée S; Bougnoux ME; Alanio A; Lanternier F; Lortholary O
    Med Mycol; 2019 Apr; 57(Supplement_2):S94-S103. PubMed ID: 30816963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Epidemiology of infections in neutropenic patients].
    Díaz-Mediavilla J; Lizasoain M
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 5():7-13. PubMed ID: 16857150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decoding the Guidelines of Invasive Pulmonary Aspergillosis in Critical Care Setting: Imaging Perspective.
    Garg A; Bhalla AS; Naranje P; Vyas S; Garg M
    Indian J Radiol Imaging; 2023 Jul; 33(3):382-391. PubMed ID: 37362371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive aspergillosis of the central nervous system in immunocompetent patients in Saudi Arabia: Case series and review of the literature.
    Taha MS; Haddad MI; Almomen AA; Abdulkader MM; Alhazmi RA
    Neurosciences (Riyadh); 2021 Oct; 26(4):379-384. PubMed ID: 34663711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and management of invasive mycoses in internal medicine: a road-map for physicians.
    Falcone M; Concia E; Iori I; Lo Cascio G; Mazzone A; Pea F; Violi F; Venditti M
    Intern Emerg Med; 2014 Aug; 9(5):501-11. PubMed ID: 24871636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.